Republican Sen. Jeff Sessions and Tom Price are two recent cabinet nominations from President-elect Donald Trump. Their track records show their hard-line on drugs, specifically marijuana, and this has people in the cannabis industry wondering if Trump is reversing the progress made in recent years. Between the two, Sessions’ appointment would be frustrating. For the hope of the cannabis industry we must anticipate that Sessions, if appointed, will take a positive outlook on medicinal marijuana and see the positive benefits—both socially and economically—it provides its patients and the rest of the United States.
Washington, DC, along with 28 other states, has legalized marijuana for either recreational or medicinal use and they have all seen some incredible benefits. There are reduced violent crime rates, no increase in youth marijuana use or traffic fatalities, as well as an increase in tax revenue. Colorado alone has shown what figures it can bring in from marijuana sales. If Trump is truly a successful businessman then bringing on the likes of Sessions and Price will clearly derail any progress United States made in the past few years. His main concern during elections was bringing in new jobs for the working class, and yet the most booming industry in America today might be overlooked by our president-elect.
Although the Trump administration is slowly looking like it might calm down progress of the medical marijuana industry, those cultivators and businessmen who are wholeheartedly in it for the long haul will continue to keep fighting even if our president-elect won’t.
Looking to find your medical cannabis in a state that hasn’t yet legalized it? It may be tempting to drive across neighboring state lines with more cannabis-friendly laws. However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. Which States Accept Out-of-State MMJ Cards? States That…
Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. But there may be some good news for those coping with this mental health issue. According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar…
The war on drugs facilitated by the federal government has been an utter failure. Despite cannabis remaining a Schedule I classification according to the federal Controlled Substances Act (CSA), meaning that it has no medicinal value, over 30 states in the United States have legalized it for its medicinal use. While this classification will remain…
Three different types of cannabidiol (CBD) oils produced by Charlotte’s Web have been banned by British regulators. The British Food Standards Agency (FSA) has also disqualified approximately 100 CBD products for undisclosed reasons. In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Despite the law’s passing, CBD…
As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. In light of this, one…
Despite the fact that the legal cannabis industry is growing, many people are still purchasing from the illicit market. A recent study…
We sat down with the team at TerraLeaf, a medical cannabis dispensary servicing West Virginia, to ask them the Veriheal 5—five questions…
Gone are the days when cannabis was just an occasional treat—today, it’s a powerful source of holistic healing. According to a 2021…